Alder BioPharmaceuticals, Inc (ALDR) Covered Calls

Alder BioPharmaceuticals Inc is a clinical-stage bio-pharmaceutical company. The Company discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

You can sell covered calls on Alder BioPharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALDR (prices last updated Mon 3:40 PM ET):

Alder BioPharmaceuticals, Inc (ALDR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.66 -0.02 12.65 12.68 230K -3.0 1.1B
Covered Calls For Alder BioPharmaceuticals, Inc (ALDR)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 12.5 0.05 12.63 -1.0% -14.0%
Jul 19 12.5 1.65 11.03 13.3% 54.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Alder Biopharmaceuticals, Inc. a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials to that inhibit the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The ALD518 is Alder's investigational monoclonal antibody to the pro-inflammatory cytokine IL-6. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.